Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Older adults' health and functional status are heterogeneous because of the various cumulative effects of chronic diseases and physiologic decline, contributing to a vicious cycle of increased frailty 1-4. Thanks to advances in medicine and hygiene, a growing number of older adults spend more years with a greater range of chronic diseases causing disability but not mortality 5. Health systems need to face this new challenge 4,5. Quantification of frailty and its association with the occurrence of incident adverse health events (i.e., functional decline, unplanned hospitalizations) is crucial to understand how health systems may efficiently respond to this situation 6. This study aims to examine the association of the ER2 tool score and its stratification in three levels for incident adverse health events in older community dwellers and to compare this association with three validity frailty indexes which are the Cardiovascular Health Study (CHS) frailty index, Study of Osteoporotic Fracture (SOF) index and Rockwood frailty index.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| NuAge participants | All Individuals of the NuAge study who agreed to be part of the NuAge Database for future research purposes |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No intervention: secondary use of a database | Other | Statistical analyses |
|
| Measure | Description | Time Frame |
|---|---|---|
| ER2 | 6-item questionnaire determining a stratification of frailty risk in three levels (Low, moderate, high) | 4 years |
| SOF index | index with 3 items determining a level of frailty from 0 (patient is vigorous) to 1 (patient is pre-frail) | 4 years |
| CHS index | index with 5 items determining a level of frailty from 0 component positive (patient is vigorous), 1 or 2 positive components (patient is in an intermediate stage) to 3 or more positive components (patients is frail) | 4 years |
| Rockwood index | index determining a level of frailty from 0 to 17 (less than 5: patient is vigorous, between 6 and 11 patient is apparently vulnerable and above 12 patient is in severe frailty) | 4 years |
| Physical functional decline | annual variation of physical functional score available in the Nuage database | 4 years |
| Falls | presence or absence of falls, information available in the Nuage database | 4 years |
| Hospitalizations | presence or absence of hospitalizations, information available in the Nuage database | 4 years |
| Mortality |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Individuals eligible for this study will be participants of the NuAge study who agreed to be part of the NuAge Database and Biobank for future research purposes
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Cyrille Launay, MD | Contact | (+1) 514 340-8222 | 23837 | cyrille.launay@mcgill.ca |
| Name | Affiliation | Role |
|---|---|---|
| Cyrille Launay, MD | Jewish General Hospital | Principal Investigator |
Not provided
The databank property is not ours. We do not have the right to share IPD.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000073496 | Frailty |
| D004630 | Emergencies |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D020969 | Disease Attributes |
Not provided
Not provided
Not provided
Not provided
Not provided
death of the participant, information available in the Nuage database |
| 4 years |